As leaders in the field of GI diseases, our expertise will enhance the efficiency of your drug development program using novel integrated approaches with cutting-edge clinical pharmacology methods and innovative translational research technologies.

Our experienced Precision Medicine team works collaboratively with Pharmaceutical and Biotechnology companies to successfully deliver Phase I-IV trials that are customized to assess compound and disease specific endpoints and identify biomarkers.

We’re committed to advancing Precision Medicine by developing new methodologies and techniques alongside our Translational Research Consortium that can be implemented in global, multicenter clinical trials.

We apply Precision Medicine to drug development through a cross-functional team approach as our Operations group collaborates seamlessly with our Scientists and Medical experts, Clinical Operations, imaging, Data Management, and Biostatistics teams. Together, we will accelerate drug development.

Our Precision Medicine solutions offer the flexibility to support you from start-to-finish in your clinical development plan. Whether it’s planning your biomarker strategy, developing an assay, analyzing samples or modeling data, we are here to help.